American Shared Hospital Services
AMS NYSEΒ· Services-Medical Laboratories
Last close Β· Oct 26, 2026
$1.25
KIRA Β· Stoqlyβs AI analyst, in plain words
- American Shared Hospital Services had $28.1M of revenue in fiscal 2025, down 0.9% on the year before. Over five years, revenue changed +9.5% a year on average.
- Its operating margin was β12.8%, down 2.9Β pts: of every 100 in sales, about β13 is left after running the business.
- American Shared Hospital Services lost $1.6M in fiscal 2025.
- Free cash flow was β$4.5M in fiscal 2025, β16.2% of revenue.
- American Shared Hospital Services owes $13.9M more than it holds in cash, about 6.6 years of operating profit.
Market cap
$8.6M
P/E
β
Revenue
$28.1M
Net income
β$1.6M
Free cash flow
β$4.5M
Operating margin
β12.8%
American Shared Hospital Services in 30 seconds Β· fiscal 2025
Are sales growing?
β0.9%
No. Sales fell 0.9% last year.
Does it make a profit?
β5.5%
No. It lost money last year.
Does profit turn into cash?
β16.2%
No. It spent more cash than it brought in.
Is debt under control?
6.6x
Heavy. Repaying its debt would take 6.6 years of operating profit.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What American Shared Hospital Services does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Legal name
- AMERICAN SHARED HOSPITAL SERVICES
- CIK
- 0000744825
American Shared Hospital Services Β· AMS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $17.6M | $19.7M | $21.3M | $28.3M | $28.1M |
| Revenue growth | β1.2% | 12.0% | 8.0% | 32.9% | β0.9% |
| Gross margin | 38.2% | 42.4% | 43.8% | 32.4% | 18.0% |
| Operating margin | 7.7% | 12.3% | 1.3% | β9.9% | β12.8% |
| Net income | $0.2M | $1.3M | $0.6M | $2.2M | β$1.6M |
| Net margin | 1.1% | 6.7% | 2.9% | 7.7% | β5.5% |
| Diluted EPS | $0.03 | $0.21 | $0.10 | $0.33 | β$0.23 |
| Cash | |||||
| Cash from operations | $6.3M | $7.2M | $5.7M | $0.2M | $3.1M |
| Capital expenditure | $1.7M | $0.4M | $6.3M | $7.9M | $7.6M |
| Free cash flow | $4.6M | $6.8M | β$0.6M | β$7.8M | β$4.5M |
| FCF margin | 26.1% | 34.7% | β2.6% | β27.4% | β16.2% |
| Share count change | β2.0% | 4.0% | 1.4% | 4.8% | β1.3% |
| Debt and strength | |||||
| Cash and short-term investments | $8.1M | $12.3M | $13.7M | $11.0M | $3.5M |
| Debt incl. finance leases | $15.7M | $13.7M | $13.3M | $20.4M | $17.4M |
| Shareholders' equity | $19.9M | $21.6M | $22.6M | $25.2M | $24.0M |
| Net debt / EBITDA | 1.2x | 0.2x | β0.1x | 2.8x | 6.6x |
| Current ratio | 2.6x | 3.6x | 1.9x | 2.5x | 0.8x |
| Interest coverage | 1.8x | 3.0x | 0.2x | β1.9x | β2.3x |
| Returns and quality | |||||
| Return on capital | 3.5% | 6.9% | 0.8% | β8.1% | β7.5% |
| Return on equity | 1.0% | 6.4% | 2.8% | 9.1% | β6.3% |
| Return on tangible equity | 1.0% | 6.5% | 2.9% | 9.2% | β6.8% |
| Piotroski F-score | 7 | 8 | 5 | 5 | 5 |
| Altman Z'' | 2.6 | 3.9 | 2.7 | 2.6 | 0.0 |
Insiders bought, 12 months
$1.3M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
American Shared Hospital Services Β· AMS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.25 a share, the company is worth $8.6M.
Source: SEC EDGAR XBRL filings (CIK 0000744825). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
